Financial News

Financial Report: BASi

Service revenue down 22% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Financial Report: BASi 4Q Revenues: $5.0 million (-23%) 4Q Loss: $721,000 (loss of $404,000 4Q14) FY Revenues: $22.7 million (-8%) FY Earnings: $1.1 million (loss of $1.1 million FY14) Comments: Service revenue for the quarter decreased 22% to $3.8 million, negatively impacted by fewer bioequivalence studies, as well as fewer samples received and analyzed. Product revenue was $1.1 million, down 25% impacted by lower sales of analytical instruments relating to Culex....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters